To test the ability of MIEL to detect short term TPCs differentiation we treated four genetically distinct glioblastoma lines with serum or BMP4, then conducted MIEL analysis using either H3K9me3 and H3K4me1 or H3K27ac and H3K27me3. Here, BMP4 is linked to glioblastoma.